Trauma and orthopaedic team members' mental health during the COVID-19 pandemic: results of a UK survey.
Covid 19
anxiety
depression
mental health
orthopaedics
pandemic
Journal
Bone & joint open
ISSN: 2633-1462
Titre abrégé: Bone Jt Open
Pays: England
ID NLM: 101770336
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
entrez:
20
11
2020
pubmed:
21
11
2020
medline:
21
11
2020
Statut:
epublish
Résumé
Healthcare systems have been rapidly restructured to meet COVID-19 demand. Clinicians are working to novel clinical guidelines, treating new patient cohorts and working in unfamiliar environments. Trauma and orthopaedics (T&O) has experienced cancellation of routine clinics and operating, with redistribution of the workload and human resources. To date, no studies have evaluated the mental health impact of these changes on the T&O workforce. We report the results of a novel survey on the impact of the pandemic on the mental health of our orthopaedic workforce and the contributory factors. A 20-question survey-based cross-sectional study of orthopaedic team members was conducted during the COVID-19 pandemic. The primary objective was to identify the impact of the pandemic on mental health in the form of major depressive disorder (MDD) and general anxiety disorder (GAD). The survey incorporated the patient health questionnaire (PHQ-2), which is validated for screening of MDD, and the generalized anxiety disorder questionnaire (GAD-2), which is validated for screening of GAD. There were 62 respondents (18 females and 44 males). As compared to the general population, we noted a greater estimated prevalence of GAD (17.7% vs 5.9%, p = 0.0009297) and MDD (19.4% vs 3.3%, p = 0.0000007731). The prevalence of MDD symptoms was greatest among senior house officers (SHOs) (p = 0.02216). Female respondents scored higher for symptoms of MDD (p = 0.03583) and GAD (p = 0.0001086). Those identifying as 'Black, African, Caribbean or Black British' displayed a higher prevalence of GAD symptoms (p = 0.001575) and felt least supported at work (p = 0.001341). Our study, in the first of its kind, shows a significant prevalence of GAD and MDD in the workforce. We found that SHOs, females and those of Black, African, Caribbean, or Black British origin were disproportionately affected. Action should be taken to help prevent adverse mental health outcomes for our colleagues during the pandemic.Cite this article:
Identifiants
pubmed: 33215120
doi: 10.1302/2046-3758.16.BJO-2020-0053.R1
pii: BJO-1-316
pmc: PMC7659657
doi:
Types de publication
Journal Article
Langues
eng
Pagination
316-325Informations de copyright
© 2020 Author(s) et al.
Références
Mayo Clin Proc. 2016 Apr;91(4):422-31
pubmed: 27046522
BMJ. 2008 Mar 1;336(7642):488-91
pubmed: 18258931
Am J Emerg Med. 2020 Jul;38(7):1530-1531
pubmed: 32336584
J Clin Psychol Med Settings. 2012 Dec;19(4):401-10
pubmed: 22327237
Evid Based Med. 2007 Oct;12(5):149
pubmed: 17909240
BMJ Open. 2016 Sep 16;6(9):e012598
pubmed: 27638497
Brain Behav. 2016 Jun 05;6(7):e00497
pubmed: 27458547
J Clin Psychiatry. 1991 May;52 Suppl:28-34
pubmed: 1903134
BMC Health Serv Res. 2014 Jul 28;14:325
pubmed: 25066375
Ann Fam Med. 2010 Jul-Aug;8(4):348-53
pubmed: 20644190
West J Emerg Med. 2015 Dec;16(7):996-1001
pubmed: 26759643
Scand J Work Environ Health. 2006 Dec;32(6):443-62
pubmed: 17173201
J Affect Disord. 2020 May 15;269:201-202
pubmed: 32339137
JAMA. 2003 Jun 18;289(23):3095-105
pubmed: 12813115